Current Status of Stem Cell Therapy and Nanofibrous Scaffolds in Cardiovascular Tissue Engineering

被引：0
作者：
Aliakbar Yousefi-Ahmadipour
Fatemeh Asadi
Ali Pirsadeghi
Niloofar Nazeri
Reza Vahidi
Mohammad Foad Abazari
Ali Afgar
Mohamad Javad Mirzaei-Parsa
机构：
[1] Rafsanjan University of Medical Sciences,Department of Laboratory Sciences, Faculty of Paramedicine
[2] Rafsanjan University of Medical Sciences,Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences
[3] Rafsanjan University of Medical Sciences,Molecular Medicine Research Center, Research Institute of Basic Medical Sciences
[4] Qazvin University of Medical Sciences,Research Institute for Prevention of Non
[5] Kerman University of Medical Sciences,Communicable Diseases
[6] Tehran University of Medical Sciences,Research Center for Hydatid Disease in Iran
[7] Kerman University of Medical Sciences,Research Center for Clinical Virology
[8] Kerman University of Medical Sciences,Cell Therapy and Regenerative Medicine Comprehensive Center
来源：
Regenerative Engineering and Translational Medicine | 2022年 / 8卷
关键词：
Cardiovascular diseases; Stem cells; Vascular regeneration; Nanofibrous scaffolds; Tissue engineering;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：248 / 268
页数：20
相关论文
共 1093 条
  • [1] Matsuzaki Y(2019)The evolution of tissue engineered vascular graft technologies: from preclinical trials to advancing patient care Appl Sci 9 1274-29
  • [2] John K(2016)Clinical status of tissue engineering and regenerative medicine in cardiovascular disease Clin Surg 2016 1021-40
  • [3] Shoji T(2018)Current strategies for the manufacture of small size tissue engineering vascular grafts Front Bioeng Biotechnol 6 41-22
  • [4] Shinoka T(2016)Advances in stem cell therapy for cardiovascular disease Int J Mol Med 38 23-2016
  • [5] Miyachi H(2017)Stem cell technology in cardiac regeneration: a pluripotent stem cell promise EBioMedicine 16 30-888
  • [6] Shoji T(2019)Stem cells: past, present, and future Stem Cell Res Ther 10 1-35
  • [7] Sugiura T(2018)Unhealthy stem cells: when health conditions upset stem cell properties Cell Physiol Biochem 46 1999-1180
  • [8] Miyamoto S(2017)Cell therapies in cardiomyopathy: current status of clinical trials Anal Cell Pathol 2017 9404057-6
  • [9] Breuer K(2018)Stem cell-derived exosome in cardiovascular diseases: macro roles of micro particles Front Pharmacol 9 547-508
  • [10] Shinoka T(2015)Scaffolds in vascular regeneration: current status Vasc Health Risk Manag 11 79-104
12345678910